Establishment Labs (ESTA) Goldman Sachs 45th Annual Global Healthcare Conference summary

Founding vision and innovation

• Founded to address lack of innovation and commitment to women's health in breast aesthetics, leveraging science and engineering for product development.

• Introduced surface technology to reduce inflammation and complications, transforming industry standards.

• Developed ergonomic and minimally invasive implants, focusing on both safety and aesthetic outcomes.

Product differentiation and education

• Emphasizes 'bench to bedside' approach, designing technology for measurable patient benefits.

• Educates surgeons globally to transition from traditional textured to smooth-like devices, adapting to local compliance rules.

• Engages patients through social media, driving demand and awareness, especially where direct communication is allowed.

Market dynamics and expansion

• Global market for technologies estimated at $2–2.2 billion, with market shares of 25–50% in most regions.

• Entered China and preparing for U.S. launch, targeting leadership in both markets.

• Innovation and premium pricing strategies, such as JoyDot and Ergonomix, drive growth and market penetration.